[1] Safar ME, Jankowski P. Central blood pressure and hypertension: role in cardiovascular risk assessment. Clin Sci (Lond) 2009; 116: 273−282. doi: 10.1042/CS20080072 [2] Safar ME, Blacher J, Pannier B, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002; 39: 735−738. doi: 10.1161/hy0202.098325 [3] Wang KL, Cheng HM, Chuang SY, et al. Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality? J Hypertens 2009; 27: 461−467. doi: 10.1097/hjh.0b013e3283220ea4 [4] Yang L, Qin B, Zhang X, et al. Association of central blood pressure and cardiovascular diseases in diabetic patients with hypertension. Medicine (Baltimore) 2017; 96: e8286. doi: 10.1097/MD.0000000000008286 [5] Dong Y, Jiang L, Wang X, et al. Central rather than brachial pressures are stronger predictors of cardiovascular outcomes: a longitudinal prospective study in a Chinese population. J Clin Hypertens (Greenwich) 2020; 22: 623−630. doi: 10.1111/jch.13838 [6] Weiner DA, Ryan TJ, Parsons L, et al. Prevalence and prognostic significance of silent and symptomatic ischemia after coronary bypass surgery: a report from the Coronary Artery Surgery Study (CASS) randomized population. J Am Coll Cardiol 1991; 18: 343−348. doi: 10.1016/0735-1097(91)90584-V [7] Eguchi K, Miyashita H, Takenaka T, et al. High central blood pressure is associated with incident cardiovascular events in treated hypertensives: the ABC-J II study. Hypertens Res 2018; 41: 947−956. doi: 10.1038/s41440-018-0075-8 [8] Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 2008; 6: 299−304. doi: 10.1089/met.2008.0034 [9] Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 2010; 95: 3347−3351. doi: 10.1210/jc.2010-0288 [10] da Silva AA, do Carmo JM, Li X, et al. Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited. Can J Cardiol 2020; 36: 671−682. doi: 10.1016/j.cjca.2020.02.066 [11] Wang Y, Yang W, Jiang X. Association between triglyceride-glucose index and hypertension: a meta-analysis. Front Cardiovasc Med 2021; 8: 644035. doi: 10.3389/fcvm.2021.644035 [12] Zheng R, Mao Y. Triglyceride and glucose (TyG) index as a predictor of incident hypertension: a 9-year longitudinal population-based study. Lipids Health Dis 2017; 16: 175. doi: 10.1186/s12944-017-0562-y [13] Jian S, Su-Mei N, Xue C, et al. Association and interaction between triglyceride-glucose index and obesity on risk of hypertension in middle-aged and elderly adults. Clin Exp Hypertens 2017; 39: 732−739. doi: 10.1080/10641963.2017.1324477 [14] Joint Committee for Guideline Revision. 2018 Chinese guidelines for prevention and treatment of hypertension: a report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J Geriatr Cardiol 2019; 16: 182−241. doi: 10.11909/j.issn.1671-5411.2019.03.014 [15] Ott C, Haetinger S, Schneider MP, et al. Comparison of two noninvasive devices for measurement of central systolic blood pressure with invasive measurement during cardiac catheterization. J Clin Hypertens (Greenwich) 2012; 14: 575−579. doi: 10.1111/j.1751-7176.2012.00682.x [16] Sánchez-Íñigo L, Navarro-González D, Pastrana-Delgado J, et al. Association of triglycerides and new lipid markers with the incidence of hypertension in a Spanish cohort. J Hypertens 2016; 34: 1257−1265. doi: 10.1097/HJH.0000000000000941 [17] Zhu B, Wang J, Chen K, et al. A high triglyceride glucose index is more closely associated with hypertension than lipid or glycemic parameters in elderly individuals: a cross-sectional survey from the Reaction study. Cardiovasc Diabetol 2020; 19: 112. doi: 10.1186/s12933-020-01077-6 [18] Morales-Gurrola G, Simental-Mendía LE, Castellanos-Juárez FX, et al. The triglycerides and glucose index is associated with cardiovascular risk factors in metabolically obese normal-weight subjects. J Endocrinol Invest 2020; 43: 995−1000. doi: 10.1007/s40618-020-01184-x [19] Bala C, Gheorghe-Fronea O, Pop D, et al. The association between six surrogate insulin resistance indexes and hypertension: a population-based study. Metab Syndr Relat Disord 2019; 17: 328−333. doi: 10.1089/met.2018.0122 [20] Terentes-Printzios D, Gardikioti V, Vlachopoulos C. Central over peripheral blood pressure: an emerging issue in hypertension research. Heart Lung Circ 2021; 30: 1667−1674. doi: 10.1016/j.hlc.2021.07.019 [21] O’Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005; 46: 200−204. doi: 10.1161/01.HYP.0000168052.00426.65 [22] Chi C, Yu X, Auckle R, et al. Hypertensive target organ damage is better associated with central than brachial blood pressure: the northern Shanghai study. J Clin Hypertens (Greenwich) 2017; 19: 1269−1275. doi: 10.1111/jch.13110 [23] Pini R, Cavallini MC, Palmieri V, et al. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano study. J Am Coll Cardiol 2008; 51: 2432−2439. doi: 10.1016/j.jacc.2008.03.031 [24] Roman MJ, Devereux RB, Kizer JR, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart study. Hypertension 2007; 50: 197−203. doi: 10.1161/HYPERTENSIONAHA.107.089078 [25] Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113: 1213−1225. doi: 10.1161/CIRCULATIONAHA.105.595496 [26] Vlachopoulos C, Aznaouridis K, O’Rourke MF, et al. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010; 31: 1865−1871. doi: 10.1093/eurheartj/ehq024 [27] Zemel MB. Insulin resistance vs. hyperinsulinemia in hypertension: insulin regulation of Ca2+ transport and Ca2+-regulation of insulin sensitivity. J Nutr 1995; 125: 1738S−1743S. doi: 10.1093/jn/125.suppl_6.1738S [28] Tack CJ, Smits P, Willemsen JJ, et al. Effects of insulin on vascular tone and sympathetic nervous system in NIDDM. Diabetes 1996; 45: 15−22. doi: 10.2337/diab.45.1.15 [29] Manrique C, Lastra G, Gardner M, et al. The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress. Med Clin North Am 2009; 93: 569−582. doi: 10.1016/j.mcna.2009.02.014 [30] Navarro-González D, Sánchez-Íñigo L, Pastrana-Delgado J, et al. Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: the Vascular-Metabolic CUN cohort. Prev Med 2016; 86: 99−105. doi: 10.1016/j.ypmed.2016.01.022 [31] Li M, Zhan A, Huang X, et al. Positive association between triglyceride glucose index and arterial stiffness in hypertensive patients: the China H-type Hypertension Registry study. Cardiovasc Diabetol 2020; 19: 139. doi: 10.1186/s12933-020-01124-2 [32] Khan SH, Sobia F, Niazi NK, et al. Metabolic clustering of risk factors: evaluation of triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetol Metab Syndr 2018; 10: 74. doi: 10.1186/s13098-018-0376-8